UPDATE: The Philadelphia Phillies have officially activated a $9 million option on reliever José Alvarado for the 2026 season. This decision comes just days after Alvarado faced an 80-game suspension that limited his participation in the 2025 season and playoffs.
Alvarado, who was sidelined due to a positive performance-enhancing drug test, is now set to return and team up with closer Jhoan Duran in a bullpen that desperately needs his experience. Before his suspension, Alvarado posted an impressive 2.70 ERA in his first 20 innings of the season, showcasing his potential as a key player for the Phillies.
In a concerning turn, Alvarado struggled upon his return in August, allowing three home runs and three walks over just six innings, resulting in a troubling 1.667 WHIP. His season ended prematurely on September 12 due to a forearm strain, raising questions about his readiness for the upcoming season.
The decision to activate his option signals the Phillies’ commitment to Alvarado as they look to solidify their pitching staff. As the team navigates the offseason, all eyes will be on how Alvarado’s return impacts the roster and the strategies they’ll employ moving forward.
With the offseason approaching, the Phillies must also consider other roster moves, including potential trades. Analysts suggest that trading veteran outfielder Nick Castellanos could be on the table to make room for strategic acquisitions.
As the situation develops, fans are eager to see how Alvarado’s comeback will unfold and what it means for the Phillies’ postseason ambitions in 2026. Stay tuned for more updates as the team prepares for the challenges ahead.
